Cargando…

The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia

Different protein kinase C (PKC) isoforms have distinct roles in regulating cell functions. The conventional (α, β, γ) and novel (δ, ɛ, η, θ) classes are targets of phorbol ester tumor promoters, which are surrogates of endogenous second messenger, diacylglycerol. The promoter‐stimulated disappearan...

Descripción completa

Detalles Bibliográficos
Autores principales: Heckman, Carol A., Pandey, Pratima, Cayer, Marilyn L., Biswas, Tania, Zhang, Zhong‐Yin, Boudreau, Nancy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575509/
https://www.ncbi.nlm.nih.gov/pubmed/28481056
http://dx.doi.org/10.1002/cm.21373
_version_ 1783260060911140864
author Heckman, Carol A.
Pandey, Pratima
Cayer, Marilyn L.
Biswas, Tania
Zhang, Zhong‐Yin
Boudreau, Nancy S.
author_facet Heckman, Carol A.
Pandey, Pratima
Cayer, Marilyn L.
Biswas, Tania
Zhang, Zhong‐Yin
Boudreau, Nancy S.
author_sort Heckman, Carol A.
collection PubMed
description Different protein kinase C (PKC) isoforms have distinct roles in regulating cell functions. The conventional (α, β, γ) and novel (δ, ɛ, η, θ) classes are targets of phorbol ester tumor promoters, which are surrogates of endogenous second messenger, diacylglycerol. The promoter‐stimulated disappearance of filopodia was investigated by use of blocking peptides (BPs) that inhibit PKC maturation and/or docking. Filopodia were partially rescued by a peptide representing PKC ɛ hydrophobic sequence, but also by a myristoylated PKC α/β pseudosubstrate sequence, and an inhibitor of T‐cell protein tyrosine phosphatase (TC‐PTP). The ability to turn over filopodia was widely distributed among PKC isoforms. PKC α and η hydrophobic sequences enhanced filopodia in cells in the absence of tumor promoter treatment. With transcriptional knockdown of PKC α, the content of PKC ɛ predominated over other isoforms. PKC ɛ could decrease filopodia significantly in promoter‐treated cells, and this was attributed to ruffling. The presence of PKC α counteracted the PKC ɛ‐mediated enhancement of ruffling. The results showed that there were two mechanisms of filopodia downregulation. One operated in the steady‐state and relied on PKC α and η. The other was stimulated by tumor promoters and relied on PKC ɛ. Cycles of protrusion and retraction are characteristic of filopodia and are essential for the cell to orient itself during chemotaxis and haptotaxis. By suppressing filopodia, PKC ɛ can create a long‐term “memory” of an environmental signal that may act in nature as a mnemonic device to mark the direction of a repulsive signal.
format Online
Article
Text
id pubmed-5575509
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55755092017-09-18 The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia Heckman, Carol A. Pandey, Pratima Cayer, Marilyn L. Biswas, Tania Zhang, Zhong‐Yin Boudreau, Nancy S. Cytoskeleton (Hoboken) Research Articles Different protein kinase C (PKC) isoforms have distinct roles in regulating cell functions. The conventional (α, β, γ) and novel (δ, ɛ, η, θ) classes are targets of phorbol ester tumor promoters, which are surrogates of endogenous second messenger, diacylglycerol. The promoter‐stimulated disappearance of filopodia was investigated by use of blocking peptides (BPs) that inhibit PKC maturation and/or docking. Filopodia were partially rescued by a peptide representing PKC ɛ hydrophobic sequence, but also by a myristoylated PKC α/β pseudosubstrate sequence, and an inhibitor of T‐cell protein tyrosine phosphatase (TC‐PTP). The ability to turn over filopodia was widely distributed among PKC isoforms. PKC α and η hydrophobic sequences enhanced filopodia in cells in the absence of tumor promoter treatment. With transcriptional knockdown of PKC α, the content of PKC ɛ predominated over other isoforms. PKC ɛ could decrease filopodia significantly in promoter‐treated cells, and this was attributed to ruffling. The presence of PKC α counteracted the PKC ɛ‐mediated enhancement of ruffling. The results showed that there were two mechanisms of filopodia downregulation. One operated in the steady‐state and relied on PKC α and η. The other was stimulated by tumor promoters and relied on PKC ɛ. Cycles of protrusion and retraction are characteristic of filopodia and are essential for the cell to orient itself during chemotaxis and haptotaxis. By suppressing filopodia, PKC ɛ can create a long‐term “memory” of an environmental signal that may act in nature as a mnemonic device to mark the direction of a repulsive signal. John Wiley and Sons Inc. 2017-05-24 2017-08 /pmc/articles/PMC5575509/ /pubmed/28481056 http://dx.doi.org/10.1002/cm.21373 Text en © 2017 The Authors. Cytoskeleton Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Heckman, Carol A.
Pandey, Pratima
Cayer, Marilyn L.
Biswas, Tania
Zhang, Zhong‐Yin
Boudreau, Nancy S.
The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
title The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
title_full The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
title_fullStr The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
title_full_unstemmed The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
title_short The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
title_sort tumor promoter‐activated protein kinase cs are a system for regulating filopodia
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575509/
https://www.ncbi.nlm.nih.gov/pubmed/28481056
http://dx.doi.org/10.1002/cm.21373
work_keys_str_mv AT heckmancarola thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT pandeypratima thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT cayermarilynl thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT biswastania thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT zhangzhongyin thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT boudreaunancys thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT heckmancarola tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT pandeypratima tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT cayermarilynl tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT biswastania tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT zhangzhongyin tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia
AT boudreaunancys tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia